BB Biotech AG (SIX: BION.SW) Stock Competitors & Peer Comparison

BB Biotech AG (SIX: BION.SW) plays a significant role within the Financial Services sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BION.SW stands at 2.7B. In comparison, RKET.SW has a market cap of 1.3B. Regarding current trading prices, BION.SW is priced at CHF 48.70 on the SIX, while RKET.SW trades at CHF 25.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BION.SW currently has a P/E ratio of 1.99, whereas RKET.SW's P/E ratio is -13.43. In terms of profitability, BION.SW's ROE is +0.50%, compared to RKET.SW's ROE of +0.24%. Regarding short-term risk, BION.SW is more volatile compared to RKET.SW. This indicates higher risk in terms of short-term price fluctuations for BION.SW.Check RKET.SW's competition here

BB Biotech AG (SIX: BION.SW) plays a significant role within the Financial Services sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BION.SW stands at 2.7B. In comparison, P1Z.SW has a market cap of 603M. Regarding current trading prices, BION.SW is priced at CHF 48.70 on the SIX, while P1Z.SW trades at CHF 21.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BION.SW currently has a P/E ratio of 1.99, whereas P1Z.SW's P/E ratio is 40.38. In terms of profitability, BION.SW's ROE is +0.50%, compared to P1Z.SW's ROE of +0.01%. Regarding short-term risk, BION.SW is more volatile compared to P1Z.SW. This indicates higher risk in terms of short-term price fluctuations for BION.SW.Check P1Z.SW's competition here

BB Biotech AG (SIX: BION.SW) plays a significant role within the Financial Services sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BION.SW stands at 2.7B. In comparison, VLRT.SW has a market cap of 26.2M. Regarding current trading prices, BION.SW is priced at CHF 48.70 on the SIX, while VLRT.SW trades at CHF 9.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BION.SW currently has a P/E ratio of 1.99, whereas VLRT.SW's P/E ratio is 10.34. In terms of profitability, BION.SW's ROE is +0.50%, compared to VLRT.SW's ROE of +0.02%. Regarding short-term risk, BION.SW is more volatile compared to VLRT.SW. This indicates higher risk in terms of short-term price fluctuations for BION.SW.Check VLRT.SW's competition here